"We are deeply concerned about the albuterol inhaler shortage, as it is now being widely used to treat COVID-19 breathing issues," the American Pharmacists Association's Ilisa Bernstein told ABC News.
"Patients, young and old, have long relied on albuterol inhalers for asthma and other breathing disorders.
Most people know albuterol inhalers for quickly treating asthma attacks or chronic obstructive pulmonary disease, a lung condition that arises from chronic smoking.
Albuterol sulfate inhaler, commonly used in the treatment of asthma as a reduce inhaler for acute asthma attack, San Ramon, California, Sept. 3, 2019.
Merck, another major manufacturer of albuterol inhalers, did not respond to requests for comment from ABC News.